Medicine · HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections)

A 31-year-old HIV-positive man (CD4 count 35 cells/μL) is diagnosed with pulmonary tuberculosis and starts antitubercular therapy today. When should antiretroviral therapy be initiated according to current guidelines?

  • A Only after completing the full course of antitubercular therapy
  • B After completing 2 months of intensive phase antitubercular therapy
  • C Within 2 weeks of starting antitubercular therapy
  • D Antiretroviral therapy should be deferred until the CD4 count exceeds 100 cells/μL
Correct answer: C. Within 2 weeks of starting antitubercular therapy

Explanation

For patients with active tuberculosis and CD4 counts below 50 cells/μL, guidelines recommend starting ART within 2 weeks of initiating antitubercular therapy, because mortality benefit outweighs the increased risk of immune reconstitution inflammatory syndrome. Patients with higher CD4 counts can wait until 8 weeks of treatment. Deferring ART until treatment completion leads to unacceptably high mortality in profoundly immunosuppressed patients.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections) MCQs

See all HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections) MCQs →